Home Infusion Therapy

Global Home Infusion Therapy Market to Reach US$63.5 Billion by 2030

The global market for Home Infusion Therapy estimated at US$43.1 Billion in the year 2024, is expected to reach US$63.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Infusion Pumps, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$29.4 Billion by the end of the analysis period. Growth in the Intravenous Sets segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.2 Billion While China is Forecast to Grow at 10.0% CAGR

The Home Infusion Therapy market in the U.S. is estimated at US$11.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.0 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Home Infusion Therapy Market - Key Trends and Drivers Summarized

Why Is Home Infusion Therapy a Game-Changer for Healthcare Delivery?

Home infusion therapy is transforming healthcare delivery by enabling patients to receive intravenous (IV) treatments, such as antibiotics, nutrition, or chemotherapy, in the comfort of their homes. This form of care is particularly beneficial for individuals with chronic conditions or infections that require long-term treatment but do not necessitate hospitalization. By receiving therapy at home, patients can maintain a higher quality of life, avoid hospital-acquired infections, and reduce healthcare costs. As healthcare systems shift toward patient-centric models of care, home infusion therapy has gained traction, offering a convenient and effective alternative to in-hospital treatments for conditions like cancer, immune deficiencies, and severe infections.

How Are Technological Innovations Shaping the Home Infusion Therapy Market?

Technological advancements in infusion devices, remote monitoring, and telehealth are significantly enhancing the home infusion therapy market. Infusion pumps have become more compact, portable, and user-friendly, allowing patients to manage their treatments with minimal assistance. Remote monitoring technologies enable healthcare providers to track patient progress, manage dosages, and detect complications in real-time, ensuring that treatments are administered safely and effectively. The integration of telehealth platforms has further improved patient care, enabling virtual consultations and providing medical guidance from healthcare professionals. These innovations are making home infusion therapy more accessible and reducing the risks associated with long-term IV therapy.

How Do Market Segments Define the Growth of the Home Infusion Therapy Industry?

Product types include infusion pumps, intravenous sets, needleless connectors, and catheters, with infusion pumps holding the largest market share due to their central role in administering precise dosages. Therapy types include antibiotic therapy, chemotherapy, hydration therapy, and parenteral nutrition, with antibiotic therapy being the most commonly administered at home. End-users of home infusion therapy include hospitals, specialty pharmacies, and home healthcare providers, with home healthcare agencies and specialty pharmacies playing an increasingly important role in delivering and managing home-based treatments.

What Factors Are Driving the Growth in the Home Infusion Therapy Market?

The growth in the home infusion therapy market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in infusion technology, and the rising demand for home-based healthcare services. As the global population ages, the incidence of chronic conditions such as cancer, diabetes, and immune disorders has increased, driving demand for long-term infusion therapy that can be administered outside of hospital settings. Technological advancements in portable infusion devices and remote monitoring systems have made it safer and more convenient for patients to receive infusion therapy at home. Additionally, the growing emphasis on reducing healthcare costs and improving patient outcomes is fueling the expansion of home infusion therapy services, as more patients seek care that enhances their quality of life while minimizing hospital stays.

SCOPE OF STUDY:

The report analyzes the Home Infusion Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors); Application (Anti-Infective, Endocrinology, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Chemotherapy, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Baxter International, Inc.
• Becton, Dickinson and Company (BD)
• Braun Melsungen AG
• BriovaRx Infusion Services
• Caesarea Medical Electronics
• CareFusion Corporation
• Cosmed
• Eli Lilly and Company
• Eitan Medical
• Fresenius Kabi
• ICU Medical, Inc.
• JMS Co. Ltd.
• Lincare Holdings, Inc.
• Moong, Inc.
• Smiths Medical
• Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.